Literature DB >> 32879389

Correction: Amyloid-β oligomers link depressive-like behavior and cognitive deficits in mice.

J H Ledo1, E P Azevedo1, J R Clarke1, F C Ribeiro1, C P Figueiredo2, D Foguel1, F G De Felice1, S T Ferreira3.   

Abstract

Entities:  

Year:  2021        PMID: 32879389      PMCID: PMC8758484          DOI: 10.1038/s41380-020-00873-6

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


× No keyword cloud information.
Correction to: Molecular Psychiatry 18, 1053–1054 (2013) 10.1038/mp.2012.168 published online 27 November 2012 It has been brought to our attention that an anonymous reader raised concerns regarding the images shown in panels 1k and 1n in our study. We have carefully investigated this issue and concluded that the representative images shown in panels 1k and 1n are indeed identical. We offer our sincere apologies for this unfortunate oversight. After careful re-examination of our data, we concluded that the image shown in panel 1n was inadvertently replicated in panel 1k when the final figure was prepared for publication. Nonetheless, and importantly, we note that this inadvertent duplication of an image did not affect the quantitative analysis of the data and corresponding statistics presented in panel 1o, and thus did not affect the conclusions of our study. We have now prepared a revised version of Fig. 1 (displayed below), in which the incorrect image presented in panel 1k has been replaced by a correct image for that experimental condition. In addition, a spreadsheet containing the original raw data used to generate the graph shown in our published paper (panel 1o) and a Prism file containing the graph generated using such raw data are provided here in the Supplementary Material section.

Fig. 1

Fig. 1 Supplementary Graph Supplementary Data
  3 in total

1.  Antioxidant Activity of Fluoxetine and Vortioxetine in a Non-Transgenic Animal Model of Alzheimer's Disease.

Authors:  Giuseppe Caruso; Margherita Grasso; Annamaria Fidilio; Sebastiano Alfio Torrisi; Nicolò Musso; Federica Geraci; Maria Rosaria Tropea; Anna Privitera; Fabio Tascedda; Daniela Puzzo; Salvatore Salomone; Filippo Drago; Gian Marco Leggio; Filippo Caraci
Journal:  Front Pharmacol       Date:  2021-12-24       Impact factor: 5.810

2.  sTREM2 mediates the associations of minimal depressive symptoms with amyloid pathology in prodromal Alzheimer's disease: The CABLE study.

Authors:  Zhi-Bo Wang; Yan Sun; Ya-Hui Ma; Yan Fu; Hao Hu; Wei Xu; Zuo-Teng Wang; Ling-Zhi Ma; Lan Tan; Jin-Tai Yu
Journal:  Transl Psychiatry       Date:  2022-04-04       Impact factor: 6.222

Review 3.  Glutamatergic System in Depression and Its Role in Neuromodulatory Techniques Optimization.

Authors:  Mohamed Adil Shah Khoodoruth; Maria Anayali Estudillo-Guerra; Kevin Pacheco-Barrios; Azan Nyundo; Gina Chapa-Koloffon; Sami Ouanes
Journal:  Front Psychiatry       Date:  2022-04-14       Impact factor: 5.435

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.